Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Zydus Lifesciences Limited
Press Release Oct 14 2024
Business
Oct 14 2024
5 min read

Press Release Oct 14 2024

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 14, 2024, titled "Zydus and ICMR initiate a Phase 2 proof-of-concept trial of Desidustat in patients with Sickle Cell Disease".

View Attachment